PAHC pahc.com: Short-Term Debt to Equity

The daily price action for Phibro Animal Health (PAHC) shown on this chart demonstrates metrics where the value is 0.06. The company's finances rely on the production of veterinary medicines, including antibiotics and vaccines for livestock. Leadership in the supplements sector and a scientific approach ensure steady demand driven by rising meat consumption. Stable cash flow is paired with mature efficiency, while profitability remains constrained by the cost of agricultural raw materials.

To implement its global expansion strategy in the biochemistry segment, Phibro Animal Health requires precise liquidity management. The current ratio of short-term loans to equity measures the proportion of liabilities due within one year relative to shareholders' equity, allowing investors to assess default risk during business scaling: a decrease in this ratio confirms financial stability, while an increase signals aggressive borrowing.